Fortis Healthcare Ltd

Fortis Healthcare Ltd maintains a debt-to-equity ratio of 0.28, indicating a relatively conservative capital structure. The company's liquidity position is characterized as medium, with a current ratio of 0.92, suggesting that it has nearly equal current assets to current liabilities. The company's free cash flow of 2,391,891,000 INR indicates a positive cash flow from operations after capital expenditures, which supports its liquidity position.

In terms of profitability, Fortis Healthcare Ltd reports a return on equity of 8.68% and a return on assets of 5.65%. These figures are below the industry median for return on equity and return on assets, suggesting that the company's profitability is not as strong as its peers. The company's operating income of 11,137,531,000 INR and net income of 7,742,152,000 INR reflect its ability to generate earnings, but the gross profit margin of 73.5% indicates that the company is managing its costs effectively.

Fortis Healthcare Ltd's revenue is concentrated in its core healthcare services and equipment segment, with no significant geographic diversification reported. The company's total revenue of 77,827,521,000 INR is primarily derived from its operations in India, with no material exposure to international markets. This concentration may pose a risk if the domestic market experiences economic downturns or regulatory changes.

The company's growth trajectory is expected to be moderate, with no significant revenue growth projected in the next fiscal year. The capital expenditure of -8,469,378,000 INR indicates that the company is investing in its operations, which could support future growth. However, the company's free cash flow and operating cash flow of 2,391,891,000 INR and 14,239,319,000 INR, respectively, suggest that it has the financial flexibility to fund its operations and investments.

The risk assessment for Fortis Healthcare Ltd indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could affect its ability to meet short-term obligations. The company's dilution risk is low, with no significant dilution potential reported. The company's capital structure and financial flexibility are key factors in managing its risk profile.

Recent events and filings for Fortis Healthcare Ltd include analyst estimates that suggest a mean price target of 1,064.12 INR and a median price target of 1,075.00 INR. The mean recommendation from analysts is 1.94, indicating a generally positive outlook. The company has received a strong-buy rating from 6 analysts and a buy rating from 6 analysts, with 3 analysts recommending a hold. These analyst ratings reflect the market's confidence in the company's future performance.